Device Trial Radar · NCT06025708
Quantra QStat Sample Type Comparison
Last checked: Nov 20, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Sep 11, 2023
Primary completion
Jan 5, 2024
Study completion Mar 1, 2024
Sponsor
- Lead sponsor
- HemoSonics LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 6, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single center prospective observational study to compare QStat parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing liver transplantation.
Conditions
- Coagulation Defect; Bleeding
Interventions
Diagnostic Test: Quantra QStat CartridgeDevice
Whole blood coagulation testing system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of QStat Clot time (CT) in arterial and venous samplesTime frame: During liver transplantation surgery
- Comparison of QStat Clot stiffness (CS) in arterial and venous samplesTime frame: During liver transplantation surgery
- Comparison of QStat Platelet Contribution to Clot stiffness (PCS) in arterial and venous samplesTime frame: During liver transplantation surgery
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ohio State University Wexner Medical Center
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.